Predictive Value of Tumor ERCC1 Expression for Treatment Outcomes After Adjuvant Chemotherapy in Patients with Completely Resected Non-Small Cell Lung Cancer
Masao Nakata,1 Shinsuke Saisho,1 Junichi Soh,2 Norihito Okumura,3 Hiroshige Nakamura,4 Motohiro Yamashita,5 Shinichi Toyooka,2 Hiroshi Date6 1Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Okayama, Japan; 2Department of General Thoracic Surgery and Breast and Endocrinolo...
Saved in:
| Main Authors: | Nakata M, Saisho S, Soh J, Okumura N, Nakamura H, Yamashita M, Toyooka S, Date H |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/predictive-value-of-tumor-ercc1-expression-for-treatment-outcomes-afte-peer-reviewed-fulltext-article-CMAR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost‐Effectiveness Analysis of Adjuvant Alectinib versus Platinum‐Based Chemotherapy in Resected ALK‐Positive Non‐Small‐Cell Lung Cancer in the Chinese Health Care System
by: Qiran Wei, et al.
Published: (2024-11-01) -
Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01) -
The impact of delayed adjuvant chemotherapy on survival in gastric cancer patients with and without preoperative chemotherapy
by: Masataka Shimonosono, et al.
Published: (2025-07-01) -
Genetic Navigation: A Narrative Review of XRCC1 Polymorphism Impact on Platinum-Based Chemotherapy Outcomes in NSCLC Patients
by: Permatasari LI, et al.
Published: (2025-02-01) -
Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)